image/svg+xml

PLATFORM THERAPY

Product pipeline alt

Dendritic Cell/Tumor Cell Fusion Vaccine + IL(Interleukin)-12

Combination therapy of fusion cell vaccine with IL-12

CyTIX developed a combination therapy by adding IL(Interleukin)-12 as an adjuvant to a fusion cell vaccine.

Clinical Research Data in Malignant Brain Tumor (Addition)therapies for many types of cancerous tumors.